Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention

Bäuerle T, Saake M, Uder M (2020)


Publication Type: Journal article, Review article

Publication year: 2020

Journal

DOI: 10.1055/a-1328-3177

Abstract

Background Radiologists have been administering gadolinium-based contrast agents (GBCA) in magnetic resonance imaging for several decades, so that there is abundant experience with these agents regarding allergic-like reactions, nephrogenic systemic fibrosis (NSF) and gadolinium retention in the brain.

Authors with CRIS profile

How to cite

APA:

Bäuerle, T., Saake, M., & Uder, M. (2020). Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention. Röfo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://dx.doi.org/10.1055/a-1328-3177

MLA:

Bäuerle, Tobias, Marc Saake, and Michael Uder. "Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention." Röfo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (2020).

BibTeX: Download